Fintech, biotech, spacetech
Payhawk, Commit Biologics, Dcubed — $280M for AI finance, immunotherapy and space hardware — Daily News November 18, 2026
01:49
•
18/11/2026
Listen on Spotify🇮🇹 Podcast in Italian
About this episode
European capital is backing platforms that turn complex technologies into operating systems for finance, immunotherapy and space infrastructure. Payhawk announced a $280M Series C at a $2B valuation, Commit Biologics completed a $60M seed and Dcubed raised €27.2M.
Europe's most interesting startup stories. Every week.
No spam. Unsubscribe anytime.
Main news
Startups mentioned
Payhawk
Spend-management platform founded in 2018 with Bulgarian roots. Its $100M Series B extension in 2022 valued it at $1 billion.
Commit Biologics
Copenhagen biotech spun out of Aarhus University, developing the BiCE platform for oncology and autoimmune diseases.
Dcubed
Spacetech based in Germering, near Munich, making release actuators, deployable hardware and solar systems for satellites.
Listen to the episode
Listen on Spotify🇮🇹 Podcast in Italian